info@shtresearch.com 
(+86)152 1082 2689
info@shtresearch.com (+86)152 1082 2689
Cart $0
We are looking for a technical partner of β-interferon on behalf of a Korean Company who develops long-acting β-interferon for MS. The company’s long-acting β-interferon is designed to be injected on the basis of Four weeks while commercial long-acting β-interferon on market is injected on the basis of Two weeks. This long-acting β-interferon is currently at pre-clinic stage in the company. The company is now looking for a potential partner company who has intention to do the R&D work together and/or to ask for technology transfer.
我司受韩国一家拥有生物长效平台技术的生物医药公司委托在中国国内寻找长效型β-干扰素及FSH（不孕症治疗剂）的合作方。目前已上市的长效型β-干扰素施药周期为2周/次，该公司长效型β-干扰素拟制定为4周/次，该产品在施药周期上较目前市面产品有很强的竞争力。该公司的这种长效型β-干扰素及FSH（不孕症治疗剂）马上要进入前临床阶段。在此该公司寻找愿意参与两种产品的共同技术研发或者申请技术转让的国内公司作为合作方。
Room A556, Cuiwei Building No.14, Haidian District, Beijing, P.R. China 
(+86)152 1082 2689
info@shtresearch.com
